1w3 min read
Medical Article
Introduction: Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by excessive platelet production, increasing the risk of thrombosis and hemorrhage (1). Current treatments aim to control platelet counts and reduce thrombotic events (1). LSD1 (lysine-specific demethylase 1) plays a role in hematopoietic cell differentiatio

Bomedemstat in a Hydroxyurea-Intolerant Patient with Essential Thrombocythemia
Similar Content

Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments

Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1008 Reached2 Comments

Treatment of Recurrent Adult Medulloblastoma
2602 Reached1 Comments4 Likes

Total Hip Arthroplasty in a Patient with Congenital Insensitivity to Pain
358 Reached4 Comments5 Likes

Chronic Cough in Adolescent
282 Reached1 Comments6 Likes
